良性脊柱肿瘤立体定向放射外科治疗的长期更新结果
该回顾性队列研究纳入1999至2016年接受立体定向放射外科(SRS)治疗的120例患者共149个良性脊柱肿瘤(39个脑膜瘤、26个神经纤维瘤、84个神经鞘瘤),中位随访49个月;3年、5年、10年局部失败累积发生率分别为2%、5%、12%,35%病灶缩小,未观察到SRS相关第二恶性肿瘤。
要点
- 中位随访49个月,3年、5年、10年局部失败累积发生率分别为2%、5%、12%。
- 排除10个既往放疗或位于既往放疗野内的肿瘤后,3年、5年、10年局部失败累积发生率分别为1%、2%、8%。
- 末次随访时35%的病灶体积缩小,776患者年随访中未观察到SRS相关第二恶性肿瘤。
核心结论
- SRS对良性脊柱肿瘤可提供长期局部控制,与良性颅内肿瘤的SRS结果相当,是手术切除的标准治疗替代方案。
研究设计与样本
- 回顾性队列研究,纳入1999至2016年接受SRS治疗的120例患者共149个良性脊柱肿瘤(39个脑膜瘤、26个神经纤维瘤、84个神经鞘瘤),并有可供回顾的随访磁共振成像。
主要发现
- 中位随访49个月(四分位距25-103个月,范围3-216个月),包括61个疗程随访超过5年、24个疗程随访超过10年。
- 共观察到9例局部失败,3年、5年、10年局部失败累积发生率分别为2%、5%、12%。
- 排除10个既往接受过放疗或位于既往放疗野内的肿瘤后,3年、5年、10年局部失败累积发生率分别为1%、2%、8%。
- 末次随访时35%的病灶体积缩小;共776患者年随访中未观察到SRS相关第二恶性肿瘤。
临床怎么用
- 作者认为SRS对良性脊柱肿瘤可提供长期局部控制,是手术切除的标准治疗替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stereotactic radiosurgery (SRS) for benign intracranial tumors is an established standard of care. The widespread implementation of SRS for benign spinal tumors has been limited by lack of long-term data. OBJECTIVE: To update our institutional experience of safety and efficacy outcomes after SRS for benign spinal tumors. METHODS: We performed a retrospective cohort study of 120 patients with 149 benign spinal tumors (39 meningiomas, 26 neurofibromas, and 84 schwannomas) treated with SRS between 1999 and 2016, with follow-up magnetic resonance imaging available for review. The primary endpoint was the cumulative incidence of local failure (LF), with death as a competing risk. Secondary endpoints included tumor shrinkage, symptom response, toxicity, and secondary malignancy. RESULTS: Median follow-up was 49 mo (interquartile range: 25-103 mo, range: 3-216 mo), including 61 courses with >5 yr and 24 courses with >10 yr of follow-up. We observed 9 LF for a cumulative incidence of LF of 2%, 5%, and 12% at 3, 5, and 10 yr, respectively. Excluding 10 tumors that were previously irradiated or that arose within a previously irradiated field, the 3-, 5-, and 10-yr cumulative incidence rates of LF were 1%, 2%, and 8%, respectively. At last follow-up, 35% of all lesions had decreased in size. With a total of 776 patient-years of follow-up, no SRS-related secondary malignancies were observed. CONCLUSION: Comparable to SRS for benign intracranial tumors, SRS provides longer term local control of benign spinal tumors and is a standard-of-care alternative to surgical resection.
引用
- Chin AL, Fujimoto D, Kumar KA, et al. Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors. Neurosurgery. 2019. PMID: 30445557. doi:10.1093/neuros/nyy442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。